Hot Movers: Opko Health Inc., Texas Instruments Incorporated, Cyberonics, Inc., Select Medical Holdings Corporation

Lakeway, NY -- (SBWIRE) -- 02/25/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Opko Health Inc. (NYSE:OPK) shares jumped 5.24% and closed at $7.03 in the last trading session. The company, on Feb. 15, announced that is has completed the acquisition of Silcon Comércio, Importacao E Exportacao de Produtos Farmaceuticos e Cosmeticos Ltda. Terms of the transaction were not disclosed.

Get Latest News, Updates on OPK Here

Texas Instruments Incorporated (NASDAQ:TXN) stock jumped 5.23% to $34.18. The company, on Feb. 21, said that is has hiked its quarterly dividend by 33% to 28 cents a share. The dividend is payable on May 20 to shareholders of record on April 30. The company also said it was adding $5 billion to its authorized share buyback program, bringing the total outstanding authorization of the program to $8.4 billion.

Is TXN a Strong Buying Opportunity After The Recent Gain? Find out Here

Cyberonics, Inc. (NASDAQ:CYBX) stock increased 5.23% to $46.65. The company, on Feb. 22, announced results for the quarter ended January 25, 2013. The company posted third quarter third quarter net sales of $62.7 million, an increase of 15% from $54.5 million in the year ago period. The company posted income per diluted share of $0.47, as compared with $0.34, an increase of 38% from the same quarter last year.

Is CYBX Signaling a Buy After The Solid gain? Don’t Miss Out Free Trend Analysis Here

Select Medical Holdings Corporation (NYSE:SEM) shares climbed 5.05% and closed at $9.16 in the last trading session. The company, on Feb. 21, confirmed the guidance it provided in its January 7, 2013 press release and expects consolidated net operating revenues for fiscal 2013 to be in the range of $2.95 billion to $3.05 billion, adjusted EBITDA to be in the range of $400.0 million to $415.0 million and fully diluted income per common share to be in the range of $0.98 to $1.04. Analysts are expecting the Company to report revenue of $3.00 billion, EBITDA of $405.4 million and EPS of $1.02 for fiscal 2013.

Additionally, SEM’s stock had its price target lowered by UBS AG from $12.00 to $9.50 in a research note released on Feb. 22. They currently have a neutral rating on the stock.

Is SEM a Strong Buying Opportunity After The Recent Surge? Get Free Trend Analysis Here

About ThePennyStockProfiler.com
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at http://www.ThePennyStockProfiler.com

Disclaimer
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.